NCT03599453
- Conditions
- Anatomic Stage IV Breast Cancer AJCC, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Progesterone Receptor Negative
Explore clinical trials studying Progesterone Receptor Negative. Study availability and eligibility vary by location and protocol.
33 public trials
1 recruiting study
Progesterone Receptor Negative trial results
NCT01846091
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +21 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Completed
Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
NCT03106077
- Conditions
- Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
IACS-010759 in Advanced Cancers
NCT03291938
- Conditions
- Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer
NCT03544125
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT01964924
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +11 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
NCT02599194
- Conditions
- Adenocarcinoma, Adenoma, B-Cell Neoplasm, +53 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
Completed
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
NCT00892736
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +48 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
NCT01624441
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01145430
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +30 more
- Locations
-
- Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
- Mount Sinai Hospital New York, United States
- Columbia University/Herbert Irving Cancer Center New York, United States
- Weill Medical College of Cornell University New York, United States